NCT04649242 Randomized Study in Children and Adolescents With Migraine: Acute Treatment Status RECRUITING Phase PHASE3
NCT04648241 Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older Status COMPLETED Phase PHASE3
NCT04647110 Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers. Status COMPLETED Phase N/A
NCT04645966 A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants Status TERMINATED Phase PHASE2
NCT04642079 Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age Status COMPLETED Phase PHASE3
NCT04638153 A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia Status TERMINATED Phase PHASE2
NCT04635631 STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS Status COMPLETED Phase PHASE1
NCT04634565 PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS Status COMPLETED Phase PHASE1
NCT04628793 A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04628780 Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT04628572 Retrospective Analysis of Real World Use of Ceftazidime-avibactam in the Management of Gram Negative Infections Status COMPLETED Phase N/A
NCT04627532 Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04624230 Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04621227 Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity Status COMPLETED Phase PHASE1
NCT04618913 Anticoagulation in Patients With Venous Thromboembolism and Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04617275 A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY Status COMPLETED Phase PHASE2
NCT04616339 STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY Status COMPLETED Phase PHASE1
NCT04616027 STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT Status COMPLETED Phase PHASE1
NCT04613375 PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older Status COMPLETED Phase N/A